 | | R6Z | | Name: | 3-(1H-tetrazol-5-yl)-N-[3-(1H-tetrazol-5-yl)phenyl]-5-(trifluoromethyl)benzamide | | Formula: | C16 H10 F3 N9 O | | SMILES: | C(=O)(c1cc(C(F)(F)F)cc(c1)c2nnnn2)Nc3cccc(c3)c4nnnn4 | | InChi: | InChI=1S/C16H10F3N9O/c17-16(18,19)11-5-9(14-23-27-28-24-14)4-10(6-11)15(29)20-12-3-1-2-8(7-12)13-21-25-26-22-13/h1-7H,(H,20,29)(H,21,22,25,26)(H,23,24,27,28) | | Definition date: | 2019-04-24 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 3-(1H-tetrazol-5-yl)-N-[3-(1H-tetrazol-5-yl)phenyl]-5-(trifluoromethyl)benzamide |
|
 | | M83 | | Name: | 5-(3-cyanophenyl)furan-2-carboxylic acid | | Formula: | C12 H7 N O3 | | SMILES: | OC(=O)c1oc(cc1)c2cccc(c2)C#N | | InChi: | InChI=1S/C12H7NO3/c13-7-8-2-1-3-9(6-8)10-4-5-11(16-10)12(14)15/h1-6H,(H,14,15) | | Definition date: | 2020-06-05 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 5-(3-cyanophenyl)furan-2-carboxylic acid |
|
 | | P92 | | Name: | 3~{H}-1,3-benzoxazole-2-thione | | Formula: | C7 H5 N O S | | SMILES: | S=C1Nc2ccccc2O1 | | InChi: | InChI=1S/C7H5NOS/c10-7-8-5-3-1-2-4-6(5)9-7/h1-4H,(H,8,10) | | Definition date: | 2020-04-18 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 3~{H}-1,3-benzoxazole-2-thione |
|
 | | P9E | | Name: | 2-sulfanylidene-3~{H}-1,3-benzoxazole-5-sulfonamide | | Formula: | C7 H6 N2 O3 S2 | | SMILES: | N[S](=O)(=O)c1ccc2OC(=S)Nc2c1 | | InChi: | InChI=1S/C7H6N2O3S2/c8-14(10,11)4-1-2-6-5(3-4)9-7(13)12-6/h1-3H,(H,9,13)(H2,8,10,11) | | Definition date: | 2020-04-18 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 2-sulfanylidene-3~{H}-1,3-benzoxazole-5-sulfonamide |
|
 | | SGG | | Name: | [(2~{S})-3-[[(1~{S})-1-(3,4-dichlorophenyl)ethyl]amino]-2-oxidanyl-propyl]-(phenylmethyl)phosphinic acid | | Formula: | C18 H22 Cl2 N O3 P | | SMILES: | C[CH](NC[CH](O)C[P](O)(=O)Cc1ccccc1)c2ccc(Cl)c(Cl)c2 | | InChi: | InChI=1S/C18H22Cl2NO3P/c1-13(15-7-8-17(19)18(20)9-15)21-10-16(22)12-25(23,24)11-14-5-3-2-4-6-14/h2-9,13,16,21-22H,10-12H2,1H3,(H,23,24)/t13-,16-/m0/s1 | | Definition date: | 2020-03-09 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | [(2~{S})-3-[[(1~{S})-1-(3,4-dichlorophenyl)ethyl]amino]-2-oxidanyl-propyl]-(phenylmethyl)phosphinic acid |
|
 | | Q2M | | Name: | 5'-{[(3S)-3-amino-3-carboxypropyl]({1-[(thiophen-2-yl)methyl]azetidin-3-yl}methyl)amino}-5'-deoxyadenosine | | Formula: | C23 H32 N8 O5 S | | SMILES: | c2nc1n(cnc1c(n2)N)C5C(C(O)C(CN(CCC(C(=O)O)N)CC3CN(C3)Cc4cccs4)O5)O | | InChi: | InChI=1S/C23H32N8O5S/c24-15(23(34)35)3-4-29(6-13-7-30(8-13)9-14-2-1-5-37-14)10-16-18(32)19(33)22(36-16)31-12-28-17-20(25)26-11-27-21(17)31/h1-2,5,11-13,15-16,18-19,22,32-33H,3-4,6-10,24H2,(H,34,35)(H2,25,26,27)/t15-,16+,18+,19+,22+/m0/s1 | | Definition date: | 2019-09-11 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 5'-{[(3S)-3-amino-3-carboxypropyl]({1-[(thiophen-2-yl)methyl]azetidin-3-yl}methyl)amino}-5'-deoxyadenosine |
|
 | | Q2P | | Name: | 5'-{[(3S)-3-amino-3-carboxypropyl]({1-[(3-chlorophenyl)methyl]azetidin-3-yl}methyl)amino}-5'-deoxyadenosine | | Formula: | C25 H33 Cl N8 O5 | | SMILES: | c2nc1n(cnc1c(N)n2)C5C(C(O)C(CN(CC3CN(C3)Cc4cccc(c4)Cl)CCC(C(O)=O)N)O5)O | | InChi: | InChI=1S/C25H33ClN8O5/c26-16-3-1-2-14(6-16)7-33-9-15(10-33)8-32(5-4-17(27)25(37)38)11-18-20(35)21(36)24(39-18)34-13-31-19-22(28)29-12-30-23(19)34/h1-3,6,12-13,15,17-18,20-21,24,35-36H,4-5,7-11,27H2,(H,37,38)(H2,28,29,30)/t17-,18+,20+,21+,24+/m0/s1 | | Definition date: | 2019-09-11 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 5'-{[(3S)-3-amino-3-carboxypropyl]({1-[(3-chlorophenyl)methyl]azetidin-3-yl}methyl)amino}-5'-deoxyadenosine |
|
 | | Q2V | | Name: | 5'-([(3S)-3-amino-3-carboxypropyl]{[1-(3,3-diphenylpropyl)azetidin-3-yl]methyl}amino)-5'-deoxyadenosine | | Formula: | C33 H42 N8 O5 | | SMILES: | n6cnc5n(C4OC(CN(CC3CN(CCC(c1ccccc1)c2ccccc2)C3)CCC(C(=O)O)N)C(C4O)O)cnc5c6N | | InChi: | InChI=1S/C33H42N8O5/c34-25(33(44)45)12-14-40(18-26-28(42)29(43)32(46-26)41-20-38-27-30(35)36-19-37-31(27)41)17-21-15-39(16-21)13-11-24(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-10,19-21,24-26,28-29,32,42-43H,11-18,34H2,(H,44,45)(H2,35,36,37)/t25-,26+,28+,29+,32+/m0/s1 | | Definition date: | 2019-09-11 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 5'-([(3S)-3-amino-3-carboxypropyl]{[1-(3,3-diphenylpropyl)azetidin-3-yl]methyl}amino)-5'-deoxyadenosine |
|
 | | Q34 | | Name: | 5'-{[(3S)-3-amino-3-carboxypropyl]({1-[(4-chlorophenyl)methyl]azetidin-3-yl}methyl)amino}-5'-deoxyadenosine | | Formula: | C25 H33 Cl N8 O5 | | SMILES: | O=C(O)C(N)CCN(CC1CN(C1)Cc2ccc(cc2)Cl)CC3C(O)C(O)C(O3)n5c4ncnc(c4nc5)N | | InChi: | InChI=1S/C25H33ClN8O5/c26-16-3-1-14(2-4-16)7-33-9-15(10-33)8-32(6-5-17(27)25(37)38)11-18-20(35)21(36)24(39-18)34-13-31-19-22(28)29-12-30-23(19)34/h1-4,12-13,15,17-18,20-21,24,35-36H,5-11,27H2,(H,37,38)(H2,28,29,30)/t17-,18+,20+,21+,24+/m0/s1 | | Definition date: | 2019-09-11 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 5'-{[(3S)-3-amino-3-carboxypropyl]({1-[(4-chlorophenyl)methyl]azetidin-3-yl}methyl)amino}-5'-deoxyadenosine |
|
 | | 7ZW | | Name: | 2-[(4~{R})-4-(2-methylpropyl)-2,5-bis(oxidanylidene)imidazolidin-1-yl]-~{N}-[4-(trifluoromethyl)phenyl]ethanamide | | Formula: | C16 H18 F3 N3 O3 | | SMILES: | CC(C)C[CH]1NC(=O)N(CC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O | | InChi: | InChI=1S/C16H18F3N3O3/c1-9(2)7-12-14(24)22(15(25)21-12)8-13(23)20-11-5-3-10(4-6-11)16(17,18)19/h3-6,9,12H,7-8H2,1-2H3,(H,20,23)(H,21,25)/t12-/m1/s1 | | Definition date: | 2020-03-12 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 2-[(4~{R})-4-(2-methylpropyl)-2,5-bis(oxidanylidene)imidazolidin-1-yl]-~{N}-[4-(trifluoromethyl)phenyl]ethanamide |
|
 | | EY1 | | Name: | 2-[(4H-1,2,4-triazol-3-yl)sulfanyl]-N-{4-[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]phenyl}acetamide | | Formula: | C20 H24 N4 O S | | SMILES: | c1cc(ccc1C24CC3CC(CC(C2)C3)C4)NC(=O)CSc5nncn5 | | InChi: | InChI=1S/C20H24N4OS/c25-18(11-26-19-21-12-22-24-19)23-17-3-1-16(2-4-17)20-8-13-5-14(9-20)7-15(6-13)10-20/h1-4,12-15H,5-11H2,(H,23,25)(H,21,22,24)/t13-,14+,15-,20- | | Definition date: | 2018-02-12 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 2-[(4H-1,2,4-triazol-3-yl)sulfanyl]-N-{4-[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]phenyl}acetamide |
|
 | | RYG | | Name: | ~{N}-[(3~{R})-2-oxidanylideneazepan-3-yl]furan-2-carboxamide | | Formula: | C11 H14 N2 O3 | | SMILES: | O=C1NCCCC[CH]1NC(=O)c2occc2 | | InChi: | InChI=1S/C11H14N2O3/c14-10-8(4-1-2-6-12-10)13-11(15)9-5-3-7-16-9/h3,5,7-8H,1-2,4,6H2,(H,12,14)(H,13,15)/t8-/m1/s1 | | Definition date: | 2020-03-02 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | ~{N}-[(3~{R})-2-oxidanylideneazepan-3-yl]furan-2-carboxamide |
|
 | | RYM | | Name: | 4-(benzimidazol-1-ylmethyl)benzenecarbonitrile | | Formula: | C15 H11 N3 | | SMILES: | N#Cc1ccc(Cn2cnc3ccccc23)cc1 | | InChi: | InChI=1S/C15H11N3/c16-9-12-5-7-13(8-6-12)10-18-11-17-14-3-1-2-4-15(14)18/h1-8,11H,10H2 | | Definition date: | 2020-03-02 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 4-(benzimidazol-1-ylmethyl)benzenecarbonitrile |
|
 | | S07 | | Name: | 2-(2,4-dimethylphenoxy)-1-morpholin-4-yl-ethanone | | Formula: | C14 H19 N O3 | | SMILES: | Cc1ccc(OCC(=O)N2CCOCC2)c(C)c1 | | InChi: | InChI=1S/C14H19NO3/c1-11-3-4-13(12(2)9-11)18-10-14(16)15-5-7-17-8-6-15/h3-4,9H,5-8,10H2,1-2H3 | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 2-(2,4-dimethylphenoxy)-1-morpholin-4-yl-ethanone |
|
 | | S0S | | Name: | (3~{R},4~{R})-1,1-bis(oxidanylidene)-4-(pyridin-3-ylmethylamino)thiolan-3-ol | | Formula: | C10 H14 N2 O3 S | | SMILES: | O[CH]1C[S](=O)(=O)C[CH]1NCc2cccnc2 | | InChi: | InChI=1S/C10H14N2O3S/c13-10-7-16(14,15)6-9(10)12-5-8-2-1-3-11-4-8/h1-4,9-10,12-13H,5-7H2/t9-,10-/m0/s1 | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | (3~{R},4~{R})-1,1-bis(oxidanylidene)-4-(pyridin-3-ylmethylamino)thiolan-3-ol |
|
 | | S0V | | Name: | morpholin-4-yl(1,2,3-thiadiazol-4-yl)methanone | | Formula: | C7 H9 N3 O2 S | | SMILES: | O=C(N1CCOCC1)c2csnn2 | | InChi: | InChI=1S/C7H9N3O2S/c11-7(6-5-13-9-8-6)10-1-3-12-4-2-10/h5H,1-4H2 | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | morpholin-4-yl(1,2,3-thiadiazol-4-yl)methanone |
|
 | | S1G | | Name: | 4-[(phenylmethyl)amino]benzoic acid | | Formula: | C14 H13 N O2 | | SMILES: | OC(=O)c1ccc(NCc2ccccc2)cc1 | | InChi: | InChI=1S/C14H13NO2/c16-14(17)12-6-8-13(9-7-12)15-10-11-4-2-1-3-5-11/h1-9,15H,10H2,(H,16,17) | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 4-[(phenylmethyl)amino]benzoic acid |
|
 | | S1J | | Name: | 3-azanyl-4-(pyridin-3-ylmethylamino)benzoic acid | | Formula: | C13 H13 N3 O2 | | SMILES: | Nc1cc(ccc1NCc2cccnc2)C(O)=O | | InChi: | InChI=1S/C13H13N3O2/c14-11-6-10(13(17)18)3-4-12(11)16-8-9-2-1-5-15-7-9/h1-7,16H,8,14H2,(H,17,18) | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 3-azanyl-4-(pyridin-3-ylmethylamino)benzoic acid |
|
 | | S1M | | Name: | methyl 2-[(2~{S})-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanoate | | Formula: | C9 H14 N2 O4 | | SMILES: | COC(=O)C[CH]1N(CCNC1=O)C(C)=O | | InChi: | InChI=1S/C9H14N2O4/c1-6(12)11-4-3-10-9(14)7(11)5-8(13)15-2/h7H,3-5H2,1-2H3,(H,10,14)/t7-/m0/s1 | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | methyl 2-[(2~{S})-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanoate |
|
 | | S1V | | Name: | 1-ethanoylpiperidine-4-carbonitrile | | Formula: | C8 H12 N2 O | | SMILES: | CC(=O)N1CCC(CC1)C#N | | InChi: | InChI=1S/C8H12N2O/c1-7(11)10-4-2-8(6-9)3-5-10/h8H,2-5H2,1H3 | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 1-ethanoylpiperidine-4-carbonitrile |
|
 | | S2J | | Name: | methyl 2-[(2~{R})-1-(ethylcarbamoyl)-3-oxidanylidene-piperazin-2-yl]ethanoate | | Formula: | C10 H17 N3 O4 | | SMILES: | CCNC(=O)N1CCNC(=O)[CH]1CC(=O)OC | | InChi: | InChI=1S/C10H17N3O4/c1-3-11-10(16)13-5-4-12-9(15)7(13)6-8(14)17-2/h7H,3-6H2,1-2H3,(H,11,16)(H,12,15)/t7-/m1/s1 | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | methyl 2-[(2~{R})-1-(ethylcarbamoyl)-3-oxidanylidene-piperazin-2-yl]ethanoate |
|
 | | S2V | | Name: | (1-methylpiperidin-4-yl) 3-fluoranylbenzoate | | Formula: | C13 H16 F N O2 | | SMILES: | CN1CCC(CC1)OC(=O)c2cccc(F)c2 | | InChi: | InChI=1S/C13H16FNO2/c1-15-7-5-12(6-8-15)17-13(16)10-3-2-4-11(14)9-10/h2-4,9,12H,5-8H2,1H3 | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | (1-methylpiperidin-4-yl) 3-fluoranylbenzoate |
|
 | | S34 | | Name: | 2-cyano-~{N}-(pyridin-4-ylmethyl)ethanamide | | Formula: | C9 H9 N3 O | | SMILES: | O=C(CC#N)NCc1ccncc1 | | InChi: | InChI=1S/C9H9N3O/c10-4-1-9(13)12-7-8-2-5-11-6-3-8/h2-3,5-6H,1,7H2,(H,12,13) | | Definition date: | 2020-03-03 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | 2-cyano-~{N}-(pyridin-4-ylmethyl)ethanamide |
|
 | | U2J | | Name: | (4S)-1-methyl-N-{(3S,5S)-5-[4-(methylcarbamoyl)-1,3-thiazol-2-yl]-1-[4-(1H-tetrazol-5-yl)benzene-1-carbonyl]pyrrolidin-3-yl}-2,6-dioxohexahydropyrimidine-4-carboxamide | | Formula: | C23 H24 N10 O5 S | | SMILES: | c1cc(ccc1c2nnnn2)C(=O)N4CC(CC4c3nc(cs3)C(NC)=O)NC(C5CC(=O)N(C(N5)=O)C)=O | | InChi: | InChI=1S/C23H24N10O5S/c1-24-19(35)15-10-39-21(26-15)16-7-13(25-20(36)14-8-17(34)32(2)23(38)27-14)9-33(16)22(37)12-5-3-11(4-6-12)18-28-30-31-29-18/h3-6,10,13-14,16H,7-9H2,1-2H3,(H,24,35)(H,25,36)(H,27,38)(H,28,29,30,31)/t13-,14-,16-/m0/s1 | | Definition date: | 2020-04-09 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | (4S)-1-methyl-N-{(3S,5S)-5-[4-(methylcarbamoyl)-1,3-thiazol-2-yl]-1-[4-(1H-tetrazol-5-yl)benzene-1-carbonyl]pyrrolidin-3-yl}-2,6-dioxohexahydropyrimidine-4-carboxamide |
|
 | | U3G | | Name: | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-{[(9Z)-octadec-9-enoyl]oxy}propyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate | | Formula: | C43 H76 N O8 P | | SMILES: | [C@H](=CCCCCCCCC)CCCCCCCC(=O)OC(COC(CCCC=C/CC=[C@H]CC=[C@H]C[C@H]=[C@H]CCCCC)=O)COP(O)(=O)OCCN | | InChi: | InChI=1S/C43H76NO8P/c1-3-5-7-9-11-13-15-17-19-20-22-23-25-27-29-31-33-35-42(45)49-39-41(40-51-53(47,48)50-38-37-44)52-43(46)36-34-32-30-28-26-24-21-18-16-14-12-10-8-6-4-2/h11,13,17-19,21-23,27,29,41H,3-10,12,14-16,20,24-26,28,30-40,44H2,1-2H3,(H,47,48)/b13-11-,19-17-,21-18-,23-22-,29-27-/t41-/m1/s1 | | Definition date: | 2020-04-13 | | Last modified: | 2020-06-26 | | Release date: | 2020-07-01 | | Identifier: | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-{[(9Z)-octadec-9-enoyl]oxy}propyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate |
|